ACVRL1 | Activin A receptor type II-like 1 | | | | |
|
| | Tissue enhanced | 0 |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | | | | | N/A |
| Cytoplasm | Tissue enhanced | 0 |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | | | | |
|
| | Tissue enhanced | 0 |
ADAMTSL4 | ADAMTS-like 4 | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ADRB1 | Adrenoceptor beta 1 | | | | |
|
| | Tissue enhanced | 0 |
AFF2 | AF4/FMR2 family, member 2 | | | | |
|
| | Tissue enhanced | 0 |
ALPPL2 | Alkaline phosphatase, placental-like 2 | | | | |
|
| | Tissue enhanced | 0 |
AMOT | Angiomotin | | | | |
|
| | Tissue enhanced | 0 |
AOC1 | Amine oxidase, copper containing 1 | | | | |
|
| | Tissue enhanced | 0 |
APLN | Apelin | | | | | |
| | Tissue enhanced | 0 |
APLNR | Apelin receptor | | | | |
|
| | Tissue enhanced | 0 |
AREG | Amphiregulin | | | | |
|
| Mitochondria | Tissue enhanced | 0 |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | | | | |
|
| Cytoplasm Nucleoli Nucleus but not nucleoli Golgi apparatus | Tissue enhanced | 0 |
ARMS2 | Age-related maculopathy susceptibility 2 | | | | | |
| | Tissue enhanced | 0 |
ARTN | Artemin | | | | | |
| | Tissue enhanced | 0 |
BIRC7 | Baculoviral IAP repeat containing 7 | | | | | N/A |
| Nucleus Cytoplasm Microtubule organizing center | Tissue enhanced | 0 |
BMP1 | Bone morphogenetic protein 1 | | | | |
|
| | Tissue enhanced | 0 |
BMP5 | Bone morphogenetic protein 5 | | | | | |
| | Tissue enhanced | 0 |
BMP6 | Bone morphogenetic protein 6 | | | | |
|
| Mitochondria Cytoplasm | Tissue enhanced | 0 |
BMP7 | Bone morphogenetic protein 7 | | | | | |
| Vesicles Nucleus Nucleoli | Tissue enhanced | 0 |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | | | | |
|
| Nucleus | Tissue enhanced | 0 |
C20orf202 | Chromosome 20 open reading frame 202 | | | | | N/A |
| | Tissue enhanced | 0 |
C2orf83 | Chromosome 2 open reading frame 83 | | | | |
|
| | Tissue enhanced | 0 |
CCNE1 | Cyclin E1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CD300LG | CD300 molecule-like family member g | | | | | N/A |
| | Tissue enhanced | 0 |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | | | | |
|
| | Tissue enhanced | 0 |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
CLDN6 | Claudin 6 | | | | | N/A |
| | Tissue enhanced | 0 |
CLEC1A | C-type lectin domain family 1, member A | | | | | N/A |
| | Tissue enhanced | 0 |
CNTN5 | Contactin 5 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
COL11A1 | Collagen, type XI, alpha 1 | | | | | N/A |
| Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
COL15A1 | Collagen, type XV, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
COL21A1 | Collagen, type XXI, alpha 1 | | | | |
|
| Vesicles Microtubule organizing center | Tissue enhanced | 0 |
COL4A1 | Collagen, type IV, alpha 1 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
COL4A2 | Collagen, type IV, alpha 2 | | | | |
|
| Vesicles | Tissue enhanced | 0 |
COL5A3 | Collagen, type V, alpha 3 | | | | |
|
| | Tissue enhanced | 0 |
COLEC12 | Collectin sub-family member 12 | | | | |
|
| Golgi apparatus Vesicles Cell Junctions | Tissue enhanced | 0 |
COX4I2 | Cytochrome c oxidase subunit IV isoform 2 (lung) | | | | | N/A |
| | Tissue enhanced | 0 |
CRLF1 | Cytokine receptor-like factor 1 | | | | |
|
| | Tissue enhanced | 0 |
CRYBB1 | Crystallin, beta B1 | | | | | |
| | Tissue enhanced | 0 |
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | | | | | N/A |
| | Tissue enhanced | 0 |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | | | | |
|
| | Tissue enhanced | 0 |
CTAG2 | Cancer/testis antigen 2 | | | | |
|
| | Tissue enhanced | 0 |
CTHRC1 | Collagen triple helix repeat containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | | | | |
|
| | Tissue enhanced | 0 |
CYTL1 | Cytokine-like 1 | | | | | |
| | Tissue enhanced | 0 |
DACT2 | Dishevelled-binding antagonist of beta-catenin 2 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
DIO3 | Deiodinase, iodothyronine, type III | | | | | |
| | Tissue enhanced | 0 |
DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | | | | | |
| Nucleus but not nucleoli Nuclear membrane Cytoplasm | Tissue enhanced | 0 |